Neurocrine Biosciences Inc. (NBIX)
Market Open
16 Oct, 04:47 PM
$
136. 19
-0.76
-0.5586%
$
14.32B Market Cap
63.27 P/E Ratio
- Div Yield
28,663 Volume
2.29 Eps
$ 136.95
Previous Close 
Want to track NBIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Neurocrine (NBIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 2 years ago
Neurocrine's Growing Sales, Profits Attracting Big Money
Sales and profits have been rocketing upwards for Neurocrine Biosciences, Inc. (NBIX), and a recent regulatory approval should continue that trend.
Fxempire | 2 years ago
Neurocrine founder-CEO Gorman to retire in October
Neurocrine Biosciences CEO Kevin Gorman will retire on Oct. 11 after three decades with the company that he founded and will be succeeded by insider Kyle Gano.
Reuters | 2 years ago
2026 © Marketlog. All Rights Reserved.
